Letter

Clostridium difficile

Improvement targets for C difficile must be valid

BMJ 2007; 334 doi: 10.1136/bmj.39169.900475.1F (Published 5 April 2007)
Cite this as: BMJ 2007;334:709.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. M A Cooper, director, infection prevention and control1,
  2. P M Hawkey, consultant medical microbiologist (peter.hawkey@heartofengland.nhs.uk)2
  1. 1Royal Wolverhampton Hospitals NHS Trust, Department of Microbiology, New Cross Hospital, Wolverhampton WV10 0QP
  2. 2West Midlands Public Health Laboratory, Birmingham Heart of England NHS Trust, Birmingham B9 5SS

    We have identified a potentially distorting factor in the delivery of reductions in Clostridium difficile rates.1 A letter sent to chief executives of trusts, primary care trusts, and strategic health authorities in England in December 2006 stated that the forthcoming NHS operating framework for 2007-8 and the NHS contract require primary care trusts to agree a local target with their acute hospital providers for a significant reduction in C difficile infections.2 The target …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular